Skip to main content
Premium Trial:

Request an Annual Quote

Howard Hughes Team Uses RNAi to Map Cell Growth Functions of Drosophila Genome

NEW YORK, Feb. 6 (GenomeWeb News) - A team of researchers led by the Howard Hughes Medical Institute published a paper in today's issue of Science in which they used a library of dsRNA to knock down and study nearly all of the genes in the Drosophila genome.


With a library of 21,000 dsRNA molecules, the researchers assayed how knocking down each gene affected cell growth. They then selected 438 genes for further characterization. According to Norbert Perrimon, who directed the study, the group is "already applying the methodology to determine the roles of genes in many other aspects of signal transduction and cell biology."


The research team on the study included scientists from HarvardMedicalSchool, the University of Heidelberg, and the Max Planck Institute for Molecular Genetics.


The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.